Timing and Determinants of Erythropoietin Deficiency in Chronic Kidney Disease
Authors:
- Lucile MercadalLMLucile Mercadal
- Marie MetzgerMMMarie Metzger
- Nicole CasadevallNCNicole Casadevall
- Jean Philippe HaymannJHJean Philippe Haymann
- Alexandre KarrasAKAlexandre Karras
- Jean-Jacques BoffaJBJean-Jacques Boffa
- Martin FlamantMFMartin Flamant
- François VrtovsnikFVFrançois Vrtovsnik
- Bénédicte StengelBSBénédicte Stengel
- Marc FroissartMFMarc Froissart
- 1 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 7 (1) , 35-42
Abstract
Summary: Background and objectives: Anemia in patients with CKD is highly related to impaired erythropoietin (EPO) response, the timing and determinants of which remain unknown. Design, setting, participants, & measurements: This study measured EPO levels and studied their relation to GFR measured by 51Cr-EDTA renal clearance (mGFR) in 336 all-stage CKD patients not receiving any erythropoiesis-stimulating agent. Results: In patients with anemia defined by World Health Organization criteria (hemoglobin [Hb] 30 ml/min per 1.73 m2, whereas they were not correlated when mGFR was r=0.09, P=0.3; P for interaction=0.01). In patients with anemia, the ratio of observed EPO to the level predicted by the equation for their Hb level decreased from 0.72 (interquartile range, 0.57–0.95) for mGFR ≥60 ml/min per 1.73 m2 to 0.36 (interquartile range, 0.16–0.69) for mGFR 30 ml/min per 1.73 m2 calls for other explanatory factors.Keywords
This publication has 48 references indexed in Scilit:
- Endogenous Erythropoietin and the Association with Inflammation and Mortality in Diabetic Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Iron control of erythroid development by a novel aconitase-associated regulatory pathwayBlood, 2010
- Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of AnemiasAdvances in Hematology, 2009
- Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidinHaematologica, 2009
- Timing of Onset of CKD-Related Metabolic ComplicationsJournal of the American Society of Nephrology, 2009
- The Effect of Altitude on Dosing and Response to Erythropoietin in ESRDJournal of the American Society of Nephrology, 2008
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failureEuropean Heart Journal, 2005
- Predictive Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Estimating Renal FunctionJournal of the American Society of Nephrology, 2005
- Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiencyThe Journal of Pediatrics, 1992